{"transactions":[{"id":779926,"issuer":{"id":5387,"kind":"organization","name":"DELCATH SYSTEMS, INC.","symbol":"DCTH"},"owners":[{"id":47461,"kind":"person","name":"CZEREPAK ELIZABETH","position":1,"cik":"0001263500","reported_name":"CZEREPAK ELIZABETH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-14T21:45:09.000Z","date":"2026-05-13","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable at the rate of one-twelfth (1/12th) per month with the first such vesting to occur on May 13, 2026 and monthly thereafter for so long as the reporting person remains a director of  the Issuer (and subject to the terms and conditions of the Issuer's 2020 Omnibus Equity Incentive Plan, as amended). The option will expire the earlier of 10 years from the grant date or, for vested options, two years from the last day of service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The option will vest and become exercisable at the rate of one-twelfth (1/12th) per month with the first such vesting to occur on May 13, 2026 and monthly thereafter for so long as the reporting person remains a director of  the Issuer (and subject to the terms and conditions of the Issuer's 2020 Omnibus Equity Incentive Plan, as amended). The option will expire the earlier of 10 years from the grant date or, for vested options, two years from the last day of service."}],"balance_after":22500,"derivative":{"exercise_price":11.61,"underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001263500-26-000004","document":"form4-05142026_050505.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872912/000126350026000004/form4-05142026_050505.xml","form_type":"4"}},{"id":1143970,"issuer":{"id":5387,"kind":"organization","name":"DELCATH SYSTEMS, INC.","symbol":"DCTH"},"owners":[{"id":47461,"kind":"person","name":"CZEREPAK ELIZABETH","position":1,"cik":"0001263500","reported_name":"CZEREPAK ELIZABETH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-19T20:10:12.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable at the rate of one-twelfth (1/12th) per month with the first such vesting to occur on May 15, 2025 and monthly thereafter for so long as the reporting person remains a director of  the Issuer (and subject to the terms and conditions of the Issuer's 2020 Omnibus Equity Incentive Plan, as amended). The option will expire the earlier of 10 years from the grant date or, for vested options, two years from the last day of service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The option will vest and become exercisable at the rate of one-twelfth (1/12th) per month with the first such vesting to occur on May 15, 2025 and monthly thereafter for so long as the reporting person remains a director of  the Issuer (and subject to the terms and conditions of the Issuer's 2020 Omnibus Equity Incentive Plan, as amended). The option will expire the earlier of 10 years from the grant date or, for vested options, two years from the last day of service."}],"balance_after":22500,"derivative":{"exercise_price":16.05,"underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001415889-25-013614","document":"form4-05192025_040507.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872912/000141588925013614/form4-05192025_040507.xml","form_type":"4"}},{"id":1501078,"issuer":{"id":5387,"kind":"organization","name":"DELCATH SYSTEMS, INC.","symbol":"DCTH"},"owners":[{"id":47461,"kind":"person","name":"CZEREPAK ELIZABETH","position":1,"cik":"0001263500","reported_name":"CZEREPAK ELIZABETH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-28T20:32:33.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable at the rate of one-twelfth (1/12th) per month with the first such vesting to occur on May 23, 2024 and monthly thereafter for so long as the reporting person remains a director of Delcath Systems, Inc. (and subject to the terms and conditions of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan, as amended). The option will expire the earlier of 10 years from the grant date or, for vested options, two years from the last day of service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The option will vest and become exercisable at the rate of one-twelfth (1/12th) per month with the first such vesting to occur on May 23, 2024 and monthly thereafter for so long as the reporting person remains a director of Delcath Systems, Inc. (and subject to the terms and conditions of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan, as amended). The option will expire the earlier of 10 years from the grant date or, for vested options, two years from the last day of service."}],"balance_after":22500,"derivative":{"exercise_price":7.85,"underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001415889-24-014678","document":"form4-05282024_080529.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872912/000141588924014678/form4-05282024_080529.xml","form_type":"4"}},{"id":1848305,"issuer":{"id":5387,"kind":"organization","name":"DELCATH SYSTEMS, INC.","symbol":"DCTH"},"owners":[{"id":47461,"kind":"person","name":"CZEREPAK ELIZABETH","position":1,"cik":"0001263500","reported_name":"CZEREPAK ELIZABETH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-22T01:18:39.000Z","date":"2023-06-12","kind":"grant","planned":false,"acquired":true,"shares":19682,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable at the rate of one-twelfth (1/12th) per month with the first such vesting to occur on July 12, 2023 and monthly thereafter for so long as the reporting person remains a director of Delcath Systems, Inc. (and subject to the terms and conditions of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan, as amended)."}],"balance_after":19682,"derivative":{"exercise_price":7.25,"expiration_date":"2033-06-12","underlying":"Common Stock","underlying_shares":19682},"source":{"system":"sec-edgar","filing":"0000899243-23-016196","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872912/000089924323016196/doc4.xml","form_type":"4"}},{"id":2053634,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":47461,"kind":"person","name":"CZEREPAK ELIZABETH","position":1,"cik":"0001263500","reported_name":"CZEREPAK ELIZABETH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2023-01-17T22:25:53.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option shall vest on a monthly basis following the grant date, subject to the Reporting Party's continued service to the Issuer through each such vesting date."}],"balance_after":350000,"derivative":{"exercise_price":8.08,"expiration_date":"2033-01-17","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0000899243-23-001870","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263500/000089924323001870/doc4.xml","form_type":"4"}},{"id":2262644,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":47461,"kind":"person","name":"CZEREPAK ELIZABETH","position":1,"cik":"0001263500","reported_name":"CZEREPAK ELIZABETH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-05-20T17:14:46.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the original number of shares subject to the option shall vest on May 18, 2023, and 1/48th of the original number of shares subject to the option shall vest on a monthly basis thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":350000,"derivative":{"exercise_price":1.51,"expiration_date":"2032-05-18","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001209191-22-031081","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919122031081/doc4.xml","form_type":"4"}},{"id":2279888,"issuer":{"id":5387,"kind":"organization","name":"DELCATH SYSTEMS, INC.","symbol":"DCTH"},"owners":[{"id":47461,"kind":"person","name":"CZEREPAK ELIZABETH","position":1,"cik":"0001263500","reported_name":"CZEREPAK ELIZABETH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-05-06T17:45:42.000Z","date":"2022-05-04","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable at the rate of one-twelfth (1/12th) per month on the first day of each month, with the first such vesting to occur on June 1, 2022 and monthly thereafter for so long as the reporting person remains a director of Delcath Systems, Inc. The option is subject to the terms and conditions of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan, as amended."}],"balance_after":9000,"derivative":{"exercise_price":6.24,"expiration_date":"2023-05-04","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0000899243-22-017041","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872912/000089924322017041/doc4.xml","form_type":"4"}},{"id":2505646,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":47461,"kind":"person","name":"CZEREPAK ELIZABETH","position":1,"cik":"0001263500","reported_name":"CZEREPAK ELIZABETH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-11-18T17:11:28.000Z","date":"2021-11-18","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the original number of shares subject to the option shall vest on December 18, 2021, and 1/12th of the original number of shares subject to the option shall vest on a monthly basis thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":100000,"derivative":{"exercise_price":6.01,"expiration_date":"2031-11-18","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-21-065539","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919121065539/doc4.xml","form_type":"4"}},{"id":2610869,"issuer":{"id":5387,"kind":"organization","name":"DELCATH SYSTEMS, INC.","symbol":"DCTH"},"owners":[{"id":47461,"kind":"person","name":"CZEREPAK ELIZABETH","position":1,"cik":"0001263500","reported_name":"CZEREPAK ELIZABETH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-08-09T20:36:22.000Z","date":"2021-08-05","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option immediately vested with respect to four-twelfths (4/12ths) of the option shares and the remaining option shares will vest and become exercisable at the rate of one-twelfth (1/12th) per month on the first day of each month for the next eight months, starting on September 1, 2021, for so long as the reporting person remains a director of Delcath Systems, Inc. (and subject to the terms and conditions of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan)."}],"balance_after":9000,"derivative":{"exercise_price":10.16,"expiration_date":"2031-08-05","underlying":"Common   Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0000899243-21-032163","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872912/000089924321032163/doc4.xml","form_type":"4"}},{"id":2966923,"issuer":{"id":5387,"kind":"organization","name":"DELCATH SYSTEMS, INC.","symbol":"DCTH"},"owners":[{"id":47461,"kind":"person","name":"CZEREPAK ELIZABETH","position":1,"cik":"0001263500","reported_name":"CZEREPAK ELIZABETH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-25T23:02:40.000Z","date":"2020-11-23","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The stock option was awarded on October 1, 2020 pursuant to the terms and conditions of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan (the \"Plan\"), subject to shareholder approval of the Plan. The Plan was approved by the stockholders of Delcath Systems, Inc. (the \"Company\") on November 23, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests ratably over the 36-month period beginning on October 1, 2020, provided that the reporting person remains a director of the Company as of each such vesting date. The option is exercisable immediately upon vesting."}],"balance_after":20000,"derivative":{"exercise_price":11.67,"expiration_date":"2030-10-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-20-032201","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872912/000089924320032201/doc4.xml","form_type":"4"}},{"id":3104773,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":47461,"kind":"person","name":"CZEREPAK ELIZABETH","position":1,"cik":"0001263500","reported_name":"CZEREPAK ELIZABETH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-19T17:02:49.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One third of the aggregate amount of option shares shall vest on each of June 18, 2021, 2022 and 2023, respectively."}],"balance_after":60000,"derivative":{"exercise_price":2.94,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-20-037982","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919120037982/doc4.xml","form_type":"4"}},{"id":3104772,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":47461,"kind":"person","name":"CZEREPAK ELIZABETH","position":1,"cik":"0001263500","reported_name":"CZEREPAK ELIZABETH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2020-06-19T17:02:49.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the restricted shares shall vest on the earlier of (1) June 18, 2021 or (2) the date of the company's 2021 Annual Meeting of Stockholders."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001209191-20-037982","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919120037982/doc4.xml","form_type":"4"}},{"id":3473026,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":47461,"kind":"person","name":"CZEREPAK ELIZABETH","position":1,"cik":"0001263500","reported_name":"CZEREPAK ELIZABETH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-02T17:12:49.000Z","date":"2019-06-20","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the option shares vested on June 20, 2019.  The remaining option shares shall vest in 25% equal annual amounts on each anniversary date of the grant over three years."}],"balance_after":20000,"derivative":{"exercise_price":8.44,"expiration_date":"2029-06-20","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-19-040441","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919119040441/doc4.xml","form_type":"4"}},{"id":3473025,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":47461,"kind":"person","name":"CZEREPAK ELIZABETH","position":1,"cik":"0001263500","reported_name":"CZEREPAK ELIZABETH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2019-07-02T17:12:49.000Z","date":"2019-06-20","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the restricted shares shall vest on the earlier of (1) June 20, 2020 or (2) the date of the company's 2020 Annual Meeting of Stockholders."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-19-040441","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919119040441/doc4.xml","form_type":"4"}},{"id":4201458,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":47461,"kind":"person","name":"CZEREPAK ELIZABETH","position":1,"cik":"0001263500","reported_name":"CZEREPAK ELIZABETH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and EVP Corp. Development"}}],"security":"Stock Options (option to buy)","published_at":"2017-09-26T22:36:33.000Z","date":"2017-09-22","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable, if at all, on March 31, 2019, in three equal one-third increments if the average daily closing price of Altimmune, Inc.'s common stock on Nasdaq for 10 consecutive trading days between September 22, 2017 and December 31, 2018 is at or above one of three specified thresholds, respectively."}],"balance_after":62500,"derivative":{"exercise_price":2.48,"exercise_date":"2019-03-31","expiration_date":"2027-09-22","underlying":"Common Stock, par value $0.0001","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001012975-17-000719","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000101297517000719/edgar.xml","form_type":"4"}},{"id":4201457,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":47461,"kind":"person","name":"CZEREPAK ELIZABETH","position":1,"cik":"0001263500","reported_name":"CZEREPAK ELIZABETH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and EVP Corp. Development"}}],"security":"Stock Options (option to buy)","published_at":"2017-09-26T22:36:33.000Z","date":"2017-09-22","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":62500,"derivative":{"exercise_price":2.48,"exercise_date":"2017-09-22","expiration_date":"2027-09-22","underlying":"Common Stock, par value $0.0001","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001012975-17-000719","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000101297517000719/edgar.xml","form_type":"4"}},{"id":4329912,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":47461,"kind":"person","name":"CZEREPAK ELIZABETH","position":1,"cik":"0001263500","reported_name":"CZEREPAK ELIZABETH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (option to buy)","published_at":"2017-05-09T00:32:50.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":18727,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Acquired pursuant to the Agreement and Plan of Merger, dated as of January 18, 2017 (as amended on March 29, 2017, the \"Merger Agreement\"), pursuant to which a wholly-owned subsidiary of the Issuer merged with and into Altimmune, Inc. (\"Altimmune\").  Pursuant to the Merger Agreement the Issuer assumed all outstanding options to purchase shares of Altimmune capital stock on a 0.749106:1 basis upon closing of the merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is currently exercisable to purchase 6,250 shares of the Issuer's Common Stock. An additional 25% of the option will vest on each of 3/2/2018, 3/2/2019, and 3/2/2020."}],"balance_after":18727,"derivative":{"exercise_price":13.38,"expiration_date":"2016-04-07","underlying":"Common Stock, par value $0.0001","underlying_shares":18727},"source":{"system":"sec-edgar","filing":"0000899243-17-012356","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000089924317012356/doc4.xml","form_type":"4"}},{"id":4329911,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":47461,"kind":"person","name":"CZEREPAK ELIZABETH","position":1,"cik":"0001263500","reported_name":"CZEREPAK ELIZABETH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (option to buy)","published_at":"2017-05-09T00:32:50.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":178595,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Acquired pursuant to the Agreement and Plan of Merger, dated as of January 18, 2017 (as amended on March 29, 2017, the \"Merger Agreement\"), pursuant to which a wholly-owned subsidiary of the Issuer merged with and into Altimmune, Inc. (\"Altimmune\").  Pursuant to the Merger Agreement the Issuer assumed all outstanding options to purchase shares of Altimmune capital stock on a 0.749106:1 basis upon closing of the merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is currently exercisable to purchase 119,207 shares of the Issuer's common stock, par value $0.0001 (\"Common Stock\"). The option to purchase the remaining 59,388 shares of Common Stock will vest in equal installments on a monthly basis until 4/7/2019."}],"balance_after":178595,"derivative":{"exercise_price":13.35,"expiration_date":"2025-05-27","underlying":"Common Stock, par value $0.0001","underlying_shares":178595},"source":{"system":"sec-edgar","filing":"0000899243-17-012356","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000089924317012356/doc4.xml","form_type":"4"}}]}